Identification of immune cell infiltration pattern and related critical genes in metastatic castration-resistant prostate cancer by bioinformatics analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of immune cell infiltration pattern and related critical genes in metastatic castration-resistant prostate cancer by bioinformatics analysis
Authors
Keywords
-
Journal
Cancer Biomarkers
Volume -, Issue -, Pages 1-15
Publisher
IOS Press
Online
2021-06-19
DOI
10.3233/cbm-203222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetics, Safety, and Antitumor Effect of Apalutamide with Abiraterone Acetate plus Prednisone in Metastatic Castration-Resistant Prostate Cancer: Phase 1b Study
- (2020) Edwin M Posadas et al. CLINICAL CANCER RESEARCH
- Chinese Expert Consensus on the Diagnosis and Treatment of Castration-Resistant Prostate Cancer (2019 Update)
- (2020) Yao Zhu et al. Cancer Management and Research
- Immunotherapy: enhancing the efficacy of this promising therapeutic in multiple cancers
- (2019) Jitwadee Inthagard et al. CLINICAL SCIENCE
- Tissue-specific quantification and localization of androgen and estrogen receptors in prostate Cancer
- (2019) Priyanka D. Sehgal et al. HUMAN PATHOLOGY
- Genomic correlates of clinical outcome in advanced prostate cancer
- (2019) Wassim Abida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer
- (2019) Jialin Meng et al. Cancer Medicine
- The BRCA2 mutation status shapes the immune phenotype of prostate cancer
- (2019) Maximilian Jenzer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
- (2019) Mark P. Labrecque et al. JOURNAL OF CLINICAL INVESTIGATION
- Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy
- (2019) Shiping Jiao et al. CELL
- Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
- (2018) A R Hansen et al. ANNALS OF ONCOLOGY
- Rebooting Human Immunology
- (2018) Mark M. Davis et al. Annual Review of Immunology
- MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1
- (2018) Quan Wang et al. Biochemistry and Cell Biology
- Palmatine suppresses glutamine-mediated interaction between pancreatic cancer and stellate cells through simultaneous inhibition of survivin and COL1A1
- (2018) Divya Chakravarthy et al. CANCER LETTERS
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
- (2018) Christos E. Kyriakopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
- (2018) David F. McDermott et al. NATURE MEDICINE
- Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
- (2018) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux
- (2018) Jake S. O’Donnell et al. SEMINARS IN CANCER BIOLOGY
- Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer
- (2018) Daniel Nava Rodrigues et al. JOURNAL OF CLINICAL INVESTIGATION
- KEYNOTE-199: Pembrolizumab (pembro) for docetaxel-refractory metastatic castration-resistant prostate cancer (mCRPC).
- (2018) Johann S. De Bono et al. JOURNAL OF CLINICAL ONCOLOGY
- The requirement for immune infiltration and organization in the tumor microenvironment for successful immunotherapy in prostate cancer
- (2018) Caroline S. Jansen et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Treatment of Metastatic Prostate Cancer in 2018
- (2018) Chung-Han Lee et al. JAMA Oncology
- Darolutamide (ODM-201) for the treatment of prostate cancer
- (2017) Neal D. Shore EXPERT OPINION ON PHARMACOTHERAPY
- The Diagnosis and Treatment of Prostate Cancer
- (2017) Mark S. Litwin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
- (2017) Alexander W Wyatt et al. JNCI-Journal of the National Cancer Institute
- Immunotherapy for the Treatment of Urothelial Carcinoma
- (2017) Nicholas M. Donin et al. JOURNAL OF UROLOGY
- Effective combinatorial immunotherapy for castration-resistant prostate cancer
- (2017) Xin Lu et al. NATURE
- Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
- (2017) Jingsong Zhang et al. Nature Communications
- Radium 223 dichloride for prostate cancer treatment
- (2017) Emmanuel Deshayes et al. Drug Design Development and Therapy
- Characterization of infiltrating lymphocytes in human benign and malignant prostate tissue
- (2017) Emelie Rådestad et al. Oncotarget
- Androgen Signaling in Prostate Cancer
- (2017) Charles Dai et al. Cold Spring Harbor Perspectives in Medicine
- Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
- (2017) Alexander W Wyatt et al. JNCI-Journal of the National Cancer Institute
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity
- (2016) Christine Pasero et al. CANCER RESEARCH
- Immunotherapy advances in uro-genital malignancies
- (2016) Raffaele Ratta et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer
- (2016) Heather H. Cheng et al. EUROPEAN UROLOGY
- Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma
- (2015) J. Bellmunt et al. ANNALS OF ONCOLOGY
- Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions
- (2015) Xiao X Wei et al. Expert Review of Vaccines
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Plasma AR and abiraterone-resistant prostate cancer
- (2015) Alessandro Romanel et al. Science Translational Medicine
- Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy
- (2014) A. B. van der Waart et al. BLOOD
- CCR5 Receptor Antagonists Block Metastasis to Bone of v-Src Oncogene-Transformed Metastatic Prostate Cancer Cell Lines
- (2014) D. Sicoli et al. CANCER RESEARCH
- Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
- (2014) Eugene D Kwon et al. LANCET ONCOLOGY
- STRING v10: protein–protein interaction networks, integrated over the tree of life
- (2014) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Signaling by the Phosphoinositide 3-Kinase Family in Immune Cells
- (2013) Klaus Okkenhaug Annual Review of Immunology
- Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death
- (2013) Simeng Wen et al. CANCER TREATMENT REVIEWS
- Design, syntheses, and characterization of pharmacophore based chemokine receptor CCR5 antagonists as anti prostate cancer agents
- (2013) Christopher K. Arnatt et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer
- (2013) Francis Maria Báo Zambra et al. HUMAN IMMUNOLOGY
- Role of PI3K/Akt signaling in memory CD8 T cell differentiation
- (2013) Eui Ho Kim et al. Frontiers in Immunology
- The Life History of 21 Breast Cancers
- (2012) Serena Nik-Zainal et al. CELL
- Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth,Angiogenesis and Metastasis
- (2012) Suveera Dhup et al. CURRENT PHARMACEUTICAL DESIGN
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
- (2012) Davis J. McCarthy et al. NUCLEIC ACIDS RESEARCH
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Characterising the castration-resistant prostate cancer population: a systematic review
- (2011) M. Kirby et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Anibamine, a natural product CCR5 antagonist, as a novel lead for the development of anti-prostate cancer agents
- (2010) Xueping Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Molecular genetics of prostate cancer: new prospects for old challenges
- (2010) M. M. Shen et al. GENES & DEVELOPMENT
- Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
- (2010) Howard I Scher et al. LANCET
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma
- (2008) Jacob A. Klapper et al. CANCER
- Prostate cancer
- (2008) Jan-Erik Damber et al. LANCET
- Immune escape as a fundamental trait of cancer: focus on IDO
- (2008) G C Prendergast ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More